You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb) – German biotech firm BioNTech announced today that it will partner with Genentech to manufacture and commercialize personalized messenger RNA-based cancer vaccines in a deal valued at up to $310 million.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Molecular tumor profiling has provided extensive value, both in tumor biology and oncology, with the development of new technologies to identify biomarkers.
This webinar will provide an overview of novel proximal and distal sampling methods that have promise to improve patient outcomes from esophageal cancer.
Most recent single-cell and spatial biology studies have focused on the network of interactions between different cell types and their spatial context.
Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.